Literature DB >> 17406079

Syphilis and other sexually transmitted diseases in HIV infection.

Jeanne Marrazzo1.   

Abstract

An ongoing resurgence of syphilis and continued transmission of other common sexually transmitted diseases (STDs) in HIV-infected patients is fueled by a number of factors, including "prevention burnout" resulting from fatigue with long-term, safer-sex behavior, use of recretional drugs (notably methamphetamine), and false sense of security associated with HIV serosorting and elevated CD4+ cell count. Annual screening for common STDs is recommended for HIV-infected patients. Issues in syphilis and herpes simplex virus-2 (HSV-2) diagnosis and treatment are discussed. New problems are briefly reviewed, which include the increased reporting of lymphogranuloma venereum and the increased frequency of fluoroquinolone-resistant gonorrhea. The recently revised Centers for Disease Control and Prevention guidelines for treatment of syphilis, HSV-2 infection, chlamydial infection, and gonorrhea are summarized. This article summarizes a presentation on syphilis and other STDs made by Jeanne Marrazzo, MD, MPH, at the International AIDS Society-USA Continuing Medical Education course in New York, in October 2006. The original presentation is available as a Webcast at www.iasusa.org.

Entities:  

Mesh:

Year:  2007        PMID: 17406079

Source DB:  PubMed          Journal:  Top HIV Med        ISSN: 1542-8826


  3 in total

Review 1.  Syphilis: continuing public health and diagnostic challenges.

Authors:  Demetre Daskalakis
Journal:  Curr HIV/AIDS Rep       Date:  2008-05       Impact factor: 5.071

Review 2.  Syphilitic myositis: a case-based review.

Authors:  Elaine Yacyshyn; Praveena Chiowchanwisawakit; Derek J Emery; Jack Jhamandas; Lothar Resch; Geoffrey Taylor
Journal:  Clin Rheumatol       Date:  2011-01-07       Impact factor: 3.650

3.  Women facing HIV. Key question on women with HIV infection: Italian consensus workshop.

Authors:  G Carosi; P Nasta; S Fiore; A Matteelli; R Cauda; E Ferrazzi; E Tamburrini; V Savasi; T Bini; M Ravizza; A Bucceri; F Vichi; R Murri; F Mazzotta; A d'Arminio Monforte
Journal:  Infection       Date:  2009-03-23       Impact factor: 7.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.